| Michael Kyle Dempsey, MD | |
|
125 Canyon Ridge Trl, Aledo, TX 76008-3706 | |
| (479) 430-9747 | |
| Not Available |
| Full Name | Michael Kyle Dempsey |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 125 Canyon Ridge Trl, Aledo, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760693667 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 390200000X (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Harris Methodist Hospital Fort Worth | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Medicine Resources, Llp | 5890688212 | 221 |
News Archive
SuperGen Inc. has announced the presentation of data that describe how its proprietary CLIMB technology was used in lead development and design of small molecule Pim kinase inhibitors (Poster 845, Abstract 2655).
The Lymphoma Research Foundation (LRF) is pleased to announce that David Frank, MD, PhD of the Dana-Farber Cancer Institute and Thomas Kipps, MD, PhD, Moores Cancer Center, University of California, San Diego are the recipients of the second round of funding under the Foundation's Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Research Initiative.
The WHO Fracture Risk Assessment Tool (FRAX-) is being used increasingly by physicians to help evaluate fracture risk and identify those people who are most in need of osteoporosis treatment. To date, FRAX- models are available for 26 countries, with more currently in planning.
A three-year, $3 million gift from the Richard J. Fasenmyer Foundation will fund research by a pair of Cleveland physicians into HIV and the body's response in autoimmune diseases.
› Verified 7 days ago
| Entity Name | Texas Medicine Resources, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376581900 PECOS PAC ID: 5890688212 Enrollment ID: O20130702000785 |
News Archive
SuperGen Inc. has announced the presentation of data that describe how its proprietary CLIMB technology was used in lead development and design of small molecule Pim kinase inhibitors (Poster 845, Abstract 2655).
The Lymphoma Research Foundation (LRF) is pleased to announce that David Frank, MD, PhD of the Dana-Farber Cancer Institute and Thomas Kipps, MD, PhD, Moores Cancer Center, University of California, San Diego are the recipients of the second round of funding under the Foundation's Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Research Initiative.
The WHO Fracture Risk Assessment Tool (FRAX-) is being used increasingly by physicians to help evaluate fracture risk and identify those people who are most in need of osteoporosis treatment. To date, FRAX- models are available for 26 countries, with more currently in planning.
A three-year, $3 million gift from the Richard J. Fasenmyer Foundation will fund research by a pair of Cleveland physicians into HIV and the body's response in autoimmune diseases.
› Verified 7 days ago
| Entity Name | Century Integrated Partners, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447615711 PECOS PAC ID: 6406151703 Enrollment ID: O20160224002152 |
News Archive
SuperGen Inc. has announced the presentation of data that describe how its proprietary CLIMB technology was used in lead development and design of small molecule Pim kinase inhibitors (Poster 845, Abstract 2655).
The Lymphoma Research Foundation (LRF) is pleased to announce that David Frank, MD, PhD of the Dana-Farber Cancer Institute and Thomas Kipps, MD, PhD, Moores Cancer Center, University of California, San Diego are the recipients of the second round of funding under the Foundation's Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Research Initiative.
The WHO Fracture Risk Assessment Tool (FRAX-) is being used increasingly by physicians to help evaluate fracture risk and identify those people who are most in need of osteoporosis treatment. To date, FRAX- models are available for 26 countries, with more currently in planning.
A three-year, $3 million gift from the Richard J. Fasenmyer Foundation will fund research by a pair of Cleveland physicians into HIV and the body's response in autoimmune diseases.
› Verified 7 days ago
| Entity Name | Texas Emergency Medicine Group, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134774722 PECOS PAC ID: 5092046482 Enrollment ID: O20191016002394 |
News Archive
SuperGen Inc. has announced the presentation of data that describe how its proprietary CLIMB technology was used in lead development and design of small molecule Pim kinase inhibitors (Poster 845, Abstract 2655).
The Lymphoma Research Foundation (LRF) is pleased to announce that David Frank, MD, PhD of the Dana-Farber Cancer Institute and Thomas Kipps, MD, PhD, Moores Cancer Center, University of California, San Diego are the recipients of the second round of funding under the Foundation's Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Research Initiative.
The WHO Fracture Risk Assessment Tool (FRAX-) is being used increasingly by physicians to help evaluate fracture risk and identify those people who are most in need of osteoporosis treatment. To date, FRAX- models are available for 26 countries, with more currently in planning.
A three-year, $3 million gift from the Richard J. Fasenmyer Foundation will fund research by a pair of Cleveland physicians into HIV and the body's response in autoimmune diseases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Kyle Dempsey, MD 125 Canyon Ridge Trl, Aledo, TX 76008-3706 Ph: (479) 430-9747 | Michael Kyle Dempsey, MD 125 Canyon Ridge Trl, Aledo, TX 76008-3706 Ph: (479) 430-9747 |
News Archive
SuperGen Inc. has announced the presentation of data that describe how its proprietary CLIMB technology was used in lead development and design of small molecule Pim kinase inhibitors (Poster 845, Abstract 2655).
The Lymphoma Research Foundation (LRF) is pleased to announce that David Frank, MD, PhD of the Dana-Farber Cancer Institute and Thomas Kipps, MD, PhD, Moores Cancer Center, University of California, San Diego are the recipients of the second round of funding under the Foundation's Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Research Initiative.
The WHO Fracture Risk Assessment Tool (FRAX-) is being used increasingly by physicians to help evaluate fracture risk and identify those people who are most in need of osteoporosis treatment. To date, FRAX- models are available for 26 countries, with more currently in planning.
A three-year, $3 million gift from the Richard J. Fasenmyer Foundation will fund research by a pair of Cleveland physicians into HIV and the body's response in autoimmune diseases.
› Verified 7 days ago
Matthew Gorman Stine, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 260 Willow Bend Dr, Aledo, TX 76008 Phone: 817-441-9252 Fax: 817-441-9282 |